#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Wolfram syndrome Osteosarcoma Thrombocytosis Adenovirus infection Gastrointestinal disorder Acute graft versus host disease in skin Oesophageal adenocarcinoma stage III Friedreich's ataxia Cervix carcinoma Pulmonary tuberculosis Acute lymphocytic leukaemia Endometrial cancer recurrent Acute leukaemia Carcinoid tumour B-cell type acute leukaemia More trials…

    Learn about Rare Diseases

    Mitochondrial myopathy Loeys-Dietz syndrome – Diagnostics Ornithine transcarbamoylase deficiency – Treatment Vascular malformation – Treatment Brain stem glioma – Basic Information Wolfram syndrome – Basic Information Epidermolysis bullosa – Basic Information IgA nephropathy – Trials in Disease Shprintzen-Goldberg syndrome SAPHO syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    TRAZODONE HYDROCHLORIDE GSKVX000000046019 Ifinatamab Deruxtecan Methionine Magrolimab Neratinib GSKVX000000048111 Pimecrolimus TEDUGLUTIDE NERANDOMILAST Pal1-15 Acetate Foscarnet Sodium Hexahydrate Bbp-398 Daxdilimab PETHIDINE HYDROCHLORIDE Ivermectin Epirubicin Hydrochloride Pemigatinib Emavusertib Riociguat More therapies…

    Learn about Your Condition

    Testicular germ cell tumour Gastric cancer recurrent Rectal cancer stage II Status epilepticus Liver transplant rejection Malignant glioma Alopecia areata Immunodeficiency congenital Infantile apnoea Post procedural infection Cardiac ventricular thrombosis Anal cancer stage II Hernia repair Polyneuropathy Cardiac disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Percutaneous Needle Fasciotomy with Methylprednisolone Acetate or Saline for Dupuytren’s Contracture in the Finger Joint

    Recruiting

    3 1 1
    Investigated Diseases:
    • Dupuytren’s contracture
    Investigated Drugs:
    • Anhydrous Lidocaine Hydrochloride
    • Methylprednisolone Acetate
    Denmark

  • Study on Ribociclib and Drug Combination for Patients with Advanced HER2-Negative, Hormone Receptor Positive Breast Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer female
    • Hormone receptor positive breast cancer
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Anastrozole
    • Exemestane
    • Fulvestrant
    Germany

  • Study on the Effects of Dexmedetomidine and Midazolam on Children’s Experience After General Anesthesia

    Recruiting

    3 1 1
    Investigated Drugs:
    • Midazolam
    France

  • Study on the Safety and Effects of ACI-7104.056 in Patients with Early Parkinson’s Disease

    Recruiting

    2 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Pd01B
    • Ioflupane (123I)
    Germany Spain

  • Study on Dexamethasone for Patients with Moderate to Severe Depression: Evaluating Its Effectiveness with Mirtazapine, Citalopram, and Nortriptyline

    Recruiting

    3 1 1
    Investigated Diseases:
    • Depression
    Investigated Drugs:
    • Betamethasone Sodium Phosphate Ph. Eur
    • Nortriptyline
    • Pregabalin
    Denmark

  • Study on Aspirin for Preventing Preeclampsia in First-Time Pregnant Women Using Assisted Reproductive Technology

    Recruiting

    3 1 1
    Investigated Diseases:
    • Pre-eclampsia
    Investigated Drugs:
    • Acetylsalicylic Acid
    France
Previous Page
1 … 572 573 574 575 576 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!